Lords Mark Industries has commenced operations at its new state-of-the-art In Vitro Diagnostics (IVD) manufacturing facility in Vasai (East), Maharashtra, marking a significant expansion in its healthcare manufacturing capabilities.
The 14,000 sq. ft. unit became operational nearly two months ahead of its scheduled August 2026 timeline, increasing the company’s total manufacturing footprint from 20,000 sq. ft. to 34,000 sq. ft. This expansion is expected to significantly enhance production capacity and operational efficiency in the diagnostics segment. The facility is designed to manufacture a portfolio of 56 ELISA test kits along with a new range of rapid diagnostic test kits, supporting growing demand for accessible and timely disease detection solutions. The company aims to strengthen its position in the healthcare diagnostics market by expanding its product offerings and scaling production capabilities. The Research & Development division within the new facility has been dedicated to the memory of Late Shri Ratan Tata and will focus on indigenous molecular biology and genetic science research to build domestic scientific capability.
Looking ahead, the company has also announced plans for a third facility in Vasai dedicated to early cancer detection research, expected to commence operations in January 2029 and named in honour of Late Dr. A.P.J. Abdul Kalam.
